FeesSafety
Pluang+

Freddie Mac prices $243.4M seasoned loan securitization to reduce mortgage portfolio risk

Company Fundamentals
26 Oct 2026, 22:15 WIB
GlobeNewsWire
View Source
Neutral
Freddie Mac prices $243.4M seasoned loan securitization to reduce mortgage portfolio risk

Freddie Mac announced the pricing of its Seasoned Loans Structured Transaction Trust (SLST) Series 2026-1, securitizing about $243.4 million in residential mortgage loans. This transaction includes $213 million in guaranteed senior and $30.4 million in non-guaranteed subordinate certificates backed by 1,282 seasoned loans, some modified to help borrowers at foreclosure risk. The move helps Freddie Mac reduce less-liquid assets and manage credit risk in its mortgage portfolio. Settlement is expected on October 29, 2026, with servicing by Select Portfolio Servicing, Selene Finance, and Newrez. This is part of Freddie Mac's broader strategy to promote liquidity and stability in the housing market.

Freddie Mac's recent $243.4 million SLST securitization is presented here with Pluang's Financials sector market data as of Oct 27, 2026 01:21 WIB. Of 142 priced Financials-sector US stocks tradable on Pluang, 88 rose and 54 fell today. Notable movers include Banco Bradesco Sa American Depositary Shares (BBD) at USD 2.89 with a 1-day change of -28.99%, Itau Unibanco Banco Holding SA Preferred shares (ITUB) at USD 7.67 down 20.73%, and Nu Holdings Ltd (NU) at USD 12.48 down 17.65%.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
35 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
35 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
47 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App